Nidogen-1 Expression is Associated with Overall Survival and Temozolomide Sensitivity in Low-grade Glioma Patients

Overview

Journal Aging (Albany NY)

Specialty Geriatrics

Date 2021 Mar 18

PMID 33735110

Citations 10

Authors

Baiwei Zhang

Cheng Xu

Junfeng Liu

Jinsheng Yang

Qinglei Gao

Fei Ye

Affiliations

Soon will be listed here.

Abstract

We investigated the prognostic significance of nidogen-1 (NID1) in glioma. Oncomine, GEPIA, UALCAN, CCGA database analyses showed that NID1 transcript levels were significantly upregulated in multiple cancer types, including gliomas. Quantitative RT-PCR analyses confirmed that NID1 expression was significantly upregulated in glioma tissues compared to paired adjacent normal brain tissue samples (n=9). NID1 silencing enhanced apoptosis and the temozolomide sensitivity of U251 and U87-MG glioma cells. Protein-protein interaction network analysis using the STRING and GeneMANIA databases showed that NID1 interacts with several extracellular matrix proteins. TIMER database analysis showed that NID1 expression in low-grade gliomas was associated with tumor infiltration of B cells, CD4 and CD8 T cells, macrophages, neutrophils, and dendritic cells. Kaplan-Meier survival curve analysis showed that low-grade gliomas patients with high NID1 expression were associated with shorter overall survival. However, NID1 expression was not associated with overall survival in glioblastoma multiforme patients. These findings demonstrate that NID1 expression in glioma tissues is associated with overall survival of low-grade glioma patients and temozolomide sensitivity. NID1 is thus a potential prognostic biomarker and therapeutic target in low-grade glioma patients.

Citing Articles

Integrating machine learning with mendelian randomization for unveiling causal gene networks in glioblastoma multiforme.

Du L, Wang P, Qiu X, Li Z, Ma J, Chen P Discov Oncol. 2025; 16(1):38.

PMID: 39804431 PMC: 11730047. DOI: 10.1007/s12672-025-01792-0.

Exploration and validation of a novel reactive oxygen species-related signature for predicting the prognosis and chemotherapy response of patients with bladder cancer.

Li Y, Zhang L, Xu G, Chen J, Zhao K, Li M Front Immunol. 2025; 15:1493528.

PMID: 39749345 PMC: 11693660. DOI: 10.3389/fimmu.2024.1493528.

Natural Killer cells at the frontline in the fight against cancer.

Coenon L, Geindreau M, Ghiringhelli F, Villalba M, Bruchard M Cell Death Dis. 2024; 15(8):614.

PMID: 39179536 PMC: 11343846. DOI: 10.1038/s41419-024-06976-0.

Association of NID2 SNPs with Glioma Risk and Prognosis in the Chinese Population.

Hao J, Huang C, Zhao W, Zhao L, Hu X, Zhang W Neuromolecular Med. 2024; 26(1):27.

PMID: 38935278 DOI: 10.1007/s12017-024-08795-0.

Unveiling the Dichotomy of Urinary Proteins: Diagnostic Insights into Breast and Prostate Cancer and Their Roles.

Feng Y, Huo Q, Li B, Yokota H Proteomes. 2024; 12(1).

PMID: 38250812 PMC: 10801584. DOI: 10.3390/proteomes12010001.

References

Konrad L, Albrecht M, Renneberg H, Ulrix W, Hoeben E, Verhoeven G . Mesenchymal entactin-1 (nidogen-1) is required for adhesion of peritubular cells of the rat testis in vitro. Eur J Cell Biol. 2000; 79(2):112-20. DOI: 10.1078/S0171-9335(04)70013-8. View

Barkovich A, Millen K, Dobyns W . A developmental and genetic classification for midbrain-hindbrain malformations. Brain. 2009; 132(Pt 12):3199-230. PMC: 2792369. DOI: 10.1093/brain/awp247. View

Rascher G, Fischmann A, Kroger S, Duffner F, Grote E, Wolburg H . Extracellular matrix and the blood-brain barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin. Acta Neuropathol. 2002; 104(1):85-91. DOI: 10.1007/s00401-002-0524-x. View

Uhlen M, Zhang C, Lee S, Sjostedt E, Fagerberg L, Bidkhori G . A pathology atlas of the human cancer transcriptome. Science. 2017; 357(6352). DOI: 10.1126/science.aan2507. View

Darbro B, Mahajan V, Gakhar L, Skeie J, Campbell E, Wu S . Mutations in extracellular matrix genes NID1 and LAMC1 cause autosomal dominant Dandy-Walker malformation and occipital cephaloceles. Hum Mutat. 2013; 34(8):1075-9. PMC: 3714376. DOI: 10.1002/humu.22351. View

Yurchenco P, McKee K, Reinhard J, Ruegg M . Laminin-deficient muscular dystrophy: Molecular pathogenesis and structural repair strategies. Matrix Biol. 2017; 71-72:174-187. PMC: 5971131. DOI: 10.1016/j.matbio.2017.11.009. View

Diamandis P, Aldape K . World Health Organization 2016 Classification of Central Nervous System Tumors. Neurol Clin. 2018; 36(3):439-447. DOI: 10.1016/j.ncl.2018.04.003. View

Zhao Z, Zhang K, Wang Q, Li G, Zeng F, Zhang Y . Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients. Genomics Proteomics Bioinformatics. 2021; 19(1):1-12. PMC: 8498921. DOI: 10.1016/j.gpb.2020.10.005. View

Titz B, Dietrich S, Sadowski T, Beck C, Petersen A, Sedlacek R . Activity of MMP-19 inhibits capillary-like formation due to processing of nidogen-1. Cell Mol Life Sci. 2004; 61(14):1826-33. PMC: 11138908. DOI: 10.1007/s00018-004-4105-0. View

10.

Willumsen N, Bager C, Leeming D, Bay-Jensen A, Karsdal M . Nidogen-1 Degraded by Cathepsin S can be Quantified in Serum and is Associated with Non-Small Cell Lung Cancer. Neoplasia. 2017; 19(4):271-278. PMC: 5344320. DOI: 10.1016/j.neo.2017.01.008. View

11.

Uhlen M, Fagerberg L, Hallstrom B, Lindskog C, Oksvold P, Mardinoglu A . Proteomics. Tissue-based map of the human proteome. Science. 2015; 347(6220):1260419. DOI: 10.1126/science.1260419. View

12.

Mann K, Deutzmann R, Aumailley M, Timpl R, Raimondi L, Yamada Y . Amino acid sequence of mouse nidogen, a multidomain basement membrane protein with binding activity for laminin, collagen IV and cells. EMBO J. 1989; 8(1):65-72. PMC: 400773. DOI: 10.1002/j.1460-2075.1989.tb03349.x. View

13.

Yurchenco P . Basement membranes: cell scaffoldings and signaling platforms. Cold Spring Harb Perspect Biol. 2011; 3(2). PMC: 3039528. DOI: 10.1101/cshperspect.a004911. View

14.

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

15.

Paulsson M . Basement membrane proteins: structure, assembly, and cellular interactions. Crit Rev Biochem Mol Biol. 1992; 27(1-2):93-127. DOI: 10.3109/10409239209082560. View

16.

Hohenester E . Structural biology of laminins. Essays Biochem. 2019; 63(3):285-295. PMC: 6744579. DOI: 10.1042/EBC20180075. View

17.

Timpl R, Dziadek M, Fujiwara S, Nowack H, Wick G . Nidogen: a new, self-aggregating basement membrane protein. Eur J Biochem. 1983; 137(3):455-65. DOI: 10.1111/j.1432-1033.1983.tb07849.x. View

18.

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

19.

Ma S, Pang C, Song L, Guo F, Sun H . The expression of ATF3, MMP-2 and maspin in tissue chip of glioma. Pak J Pharm Sci. 2015; 28(3 Suppl):1059-63. View

20.

Dziadek M . Role of laminin-nidogen complexes in basement membrane formation during embryonic development. Experientia. 1995; 51(9-10):901-13. DOI: 10.1007/BF01921740. View